![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)
Case study: Removing Silos in End-to-End Supply Chain Planning
By KinaxisAs a company with a 125-year history of improving the health and well-being of people worldwide, MSD (known as Merck & Co in the US and Canada) recognised that significant improvements to the company’s bottom line would come through the transformation of its supply chain.
With an eye on synchronizing data and enabling access to it across all divisions in the company, better business decision making was quickly realised.
![](https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/images/WhitePaper_Default_icon.png)